S. Michael Owens
Gründer bei InterveXion Therapeutics LLC
Profil
S.
Michael Owens is the founder of InterveXion Therapeutics LLC, founded in 2004, where he holds the title of Chief Scientific Officer.
He was also the founder of Arkansas Biosciences Institute, founded in 2001, where he held the title of Director in 2002.
Currently, Dr. Owens holds the title of Principal at The University of Arkansas.
Aktive Positionen von S. Michael Owens
| Unternehmen | Position | Beginn |
|---|---|---|
InterveXion Therapeutics LLC
 InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Gründer | 17.09.2009 |
| The University of Arkansas | Corporate Officer/Principal | 17.09.2009 |
Ehemalige bekannte Positionen von S. Michael Owens
| Unternehmen | Position | Ende |
|---|---|---|
| Arkansas Biosciences Institute | Gründer | 01.01.2002 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
InterveXion Therapeutics LLC
InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Health Technology |
| Arkansas Biosciences Institute |
